E85.0

Non-neuropathic heredofamilial amyloidosis

Billable FY2026 2025-10-01 → 2026-09-30

Exclusions 9 never code together

Excludes2

E85code

Excludes2

Excludes1

androgen insensitivity syndrome (E34.5-)E34.5-
congenital adrenal hyperplasia (E25.0)E25.0
hemolytic anemias attributable to enzyme disorders (D55.-)D55.-
Marfan syndrome (Q87.4-)Q87.4-
5-alpha-reductase deficiency (E29.1)E29.1

Excludes2

Excludes1

transitory endocrine and metabolic disorders specific to newborn (P70-P74)P70-P74

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 4

Inclusion terms

Code also

Notes

All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.E05.8 E07.0 E16-E31 E34.-

Index entries leading here 5

Nephropathy N28.9
- amyloid, hereditary E85.0
Myopathy G72.9
- in (due to)
  - amyloidosis E85.0
Amyloidosis (generalized) (primary) E85.9
- non-neuropathic heredofamilial E85.0
Peritonitis (adhesive) (bacterial) (fibrinous) (hemorrhagic) (idiopathic) (localized) (perforative) (primary) (with adhesions) (with effusion) K65.9
- paroxysmal, familial E85.0
  - benign E85.0
- periodic, familial E85.0
Polyserositis
- periodic, familial E85.0

Alongside this code 6 same parent — E85

Additional references

AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

CMS22HCC23 CMS28HCC50 ESRD21HCC23 ESRD24HCC23

Presence is a property of the code. Untick a model to hide it everywhere.

Present FY2024–FY2027.